SNK01 Clinical Trials
2 recruitingBiologic
Phase 22Phase 11
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Clinical Study of SNK01 in Participants With Moderate Alzheimer's Disease
Moderate Alzheimer Disease
NKGen Biotech, Inc.36 enrolled8 locationsNCT06189963
Recruiting
Phase 2
Open-Label Extension Protocol to SNK01-AD01 Study
Alzheimer Disease
NKGen Biotech, Inc.30 enrolled1 locationNCT07228078